
|Videos|December 14, 2021
Dr. Kutikov discusses recent NCCN guideline reversal on active surveillance
Author(s)Urology Times staff
“Seeing the social media chatter, I think there is tremendous support for walking this back,” says Alexander Kutikov, MD, FACS.
Advertisement
In this video, Alexander Kutikov, MD, FACS, discusses the recent National Comprehensive Cancer Network guideline reversal regarding active surveillance in men with low-risk prostate cancer. Kutikov is the chief of the division of urology and urologic oncology, professor in the department of surgical oncology, and the Roberta R. Scheller Chair in urologic oncology at the Fox Chase Cancer Center at Temple University in Philadelphia, Pennsylvania.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Treatment Selection in Advanced Prostate Cancer
3
Pearls & Perspectives: Leadership and Prostate Cancer, with Mark L. Gonzalgo, MD, PhD, MBA
4
Advice for the Next Generation of Urologists in mCSPC Management
5






